WCN25-508 COMPARATIVE ADHERENCE AND PERSISTENCE TO DPP-4 INHIBITORS VERSUS SGLT 2 INHIBITOR IN TYPE 2 DIABETES PATIENTS WITH CHRONIC KIDNEY DISEASE : A PROSPECTIVE COHORT STUDY IN NORTH INDIA

The hospital survival rate for patients undergoing acute PD was 67%.Survival differences were linked to the underlying causes of AKI-such as, refractory heart failure, acute pancreatitis, hepatic failure, septic shock, or other causes-as well as the use of inotropes, ventilatorsupport, and the Simplified Acute Physiology Score (SAPS) II.The age of the patient was statistically insignificant (p-value 0.44) but etiology was statistically significant (p-value 0.0001) in mortality comparison.A significant proportion of survivors (51.1% [45/88]) required maintenance dialysis, primarily due to AKI resulting from heart or hepatic failures.The rates of metabolic and fluid control were 68%, and the technical success rate for acute PD was 93%.Conclusions: Acute PD, in developing countries with limited resources, continues to be an effective treatment option for patients with AKI/ ACKD with hemodynamic instability, even in the current era of continuous renal replacement therapy (CRRT).Nearly all patients in need of dialysis can undergo acute PD without encountering mechanical difficulties.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.